In this model, CSF-1/CSF-1R targeting resulted in increased expression of immune checkpoint molecule on tumour cells, including PD-L1 and CTLA-4, thus resulting in only modest increase of CD8+ T cell cytotoxicity. The gene discussed is CSF1R; the disease is neoplasm.